• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Managing Nonalcoholic Fatty Liver Disease Through Structured Lifestyle Modification Interventions.通过结构化生活方式改变干预措施管理非酒精性脂肪性肝病
Am J Lifestyle Med. 2025 May 26:15598276251346717. doi: 10.1177/15598276251346717.
2
Nonalcoholic fatty liver disease: a systematic review.非酒精性脂肪性肝病:系统评价。
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
3
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.AGA 临床实践更新:瘦个体中非酒精性脂肪性肝病的诊断和管理:专家评论。
Gastroenterology. 2022 Sep;163(3):764-774.e1. doi: 10.1053/j.gastro.2022.06.023. Epub 2022 Jul 14.
4
Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study.非酒精性脂肪性肝病患者真实世界观察性队列的设计与原理:TARGET-NASH研究
Contemp Clin Trials. 2017 Oct;61:33-38. doi: 10.1016/j.cct.2017.07.015. Epub 2017 Jul 19.
5
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.当前和新兴的非酒精性脂肪性肝病生物标志物和影像学手段:临床和研究应用。
Clin Ther. 2021 Sep;43(9):1505-1522. doi: 10.1016/j.clinthera.2021.07.012. Epub 2021 Aug 13.
6
Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.非酒精性脂肪性肝病与肝纤维化分期。
Adv Exp Med Biol. 2024;1460:539-574. doi: 10.1007/978-3-031-63657-8_18.
7
Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.非酒精性脂肪性肝病:一种新出现的现代心血管疾病风险因素。
Cureus. 2022 May 30;14(5):e25495. doi: 10.7759/cureus.25495. eCollection 2022 May.
8
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review.当前非酒精性脂肪性肝病筛查、诊断和管理临床指南与实际临床实践之间的差异:有针对性的文献回顾。
Expert Rev Gastroenterol Hepatol. 2021 Nov;15(11):1253-1266. doi: 10.1080/17474124.2021.1974295. Epub 2021 Sep 21.
9
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
10
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).印度国家肝脏研究协会(INASL)关于非酒精性脂肪性肝病(NAFLD)命名、诊断和治疗的指导文件。
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.

本文引用的文献

1
Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.代谢相关脂肪性肝病-5(MAF-5)评分预测代谢相关脂肪性肝病患者的肝脏纤维化风险和结局。
Gastroenterology. 2024 Jul;167(2):357-367.e9. doi: 10.1053/j.gastro.2024.03.017. Epub 2024 Mar 19.
2
The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢综合征严重程度对代谢功能障碍相关脂肪性肝病的种族和民族差异的影响。
PLoS One. 2024 Mar 15;19(3):e0299836. doi: 10.1371/journal.pone.0299836. eCollection 2024.
3
Mobile App-Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.基于移动应用的生活方式干预对非酒精性脂肪性肝病患者的效果:随机对照试验。
J Med Internet Res. 2024 Feb 15;26:e49839. doi: 10.2196/49839.
4
NAFLD and NASH: etiology, targets and emerging therapies.非酒精性脂肪性肝病和非酒精性脂肪性肝炎:病因、靶点及新兴疗法。
Drug Discov Today. 2024 Mar;29(3):103910. doi: 10.1016/j.drudis.2024.103910. Epub 2024 Feb 1.
5
Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics.儿科非酒精性脂肪性肝病的饮食和营养干预。
Nutrients. 2023 Nov 18;15(22):4829. doi: 10.3390/nu15224829.
6
The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients.严重代谢功能障碍相关脂肪性肝病患者肝移植的结局
Biomedicines. 2023 Nov 20;11(11):3096. doi: 10.3390/biomedicines11113096.
7
Review of paediatric obesity and non-alcoholic fatty liver disease-A focus on emerging non-pharmacologic treatment strategies.儿科肥胖与非酒精性脂肪性肝病的综述——关注新兴的非药物治疗策略。
Pediatr Obes. 2023 Oct;18(10):e13067. doi: 10.1111/ijpo.13067. Epub 2023 Aug 21.
8
You Are What You Eat: A Review on Dietary Interventions for Treating Pediatric Nonalcoholic Fatty Liver Disease.你吃什么就是什么:饮食干预治疗小儿非酒精性脂肪肝疾病述评。
Nutrients. 2023 Jul 28;15(15):3350. doi: 10.3390/nu15153350.
9
Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review.非酒精性脂肪性肝病患者的饮食策略:从证据到日常临床实践的系统评价。
United European Gastroenterol J. 2023 Sep;11(7):663-689. doi: 10.1002/ueg2.12443. Epub 2023 Jul 25.
10
Increasing nonalcoholic fatty liver disease-related mortality rates in the United States from 1999 to 2022.美国非酒精性脂肪性肝病相关死亡率从 1999 年到 2022 年呈上升趋势。
Hepatol Commun. 2023 Jul 3;7(7). doi: 10.1097/HC9.0000000000000207. eCollection 2023 Jul 1.

通过结构化生活方式改变干预措施管理非酒精性脂肪性肝病

Managing Nonalcoholic Fatty Liver Disease Through Structured Lifestyle Modification Interventions.

作者信息

Thomas Andrew, Thomas Annie

机构信息

Internal Medicine, Southern Illinois Healthcare, Carbondale, IL, USA (AT).

Marcella Niehoff School of Nursing, Loyola University Chicago, Maywood, IL, USA (AT).

出版信息

Am J Lifestyle Med. 2025 May 26:15598276251346717. doi: 10.1177/15598276251346717.

DOI:10.1177/15598276251346717
PMID:40438150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12106371/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a significant global health burden. It comprises a broad pathological spectrum ranging from simple liver steatosis to steatohepatitis with variable degrees of fibrosis, and liver failure. Patients with NAFLD have an increased risk of liver-related and overall mortality. While the trials to assess the efficacy of the medications are ongoing, lifestyle modification is the first line of therapy recommended. The primary aim of this review paper is to synthesize literature related to current evidence-based lifestyle interventions for preventing and managing NAFLD. The review and synthesis of the literature reveal that personalized nutritional, exercise, and behavior change interventions are effective in managing NAFLD. Evidence suggests that there are several gaps in managing NAFLD. The gaps discussed in this paper include a lack of awareness of the disease, ineffective patient-provider communication, shortage of specialists, under-recognition of the disease, and liver health disparities. This paper highlights the evidence-based opportunities to overcome those gaps, such as utilizing comprehensive models of care, clinical care pathways, and clinical practice guidelines. Primary care physicians and endocrinologists, who are the first point of contact must utilize these opportunities for diagnosing and managing patients with NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是一项重大的全球健康负担。它包括从单纯性肝脂肪变性到伴有不同程度纤维化和肝衰竭的脂肪性肝炎的广泛病理谱。NAFLD患者发生肝脏相关死亡和全因死亡的风险增加。虽然评估药物疗效的试验正在进行中,但生活方式改变是推荐的一线治疗方法。这篇综述论文的主要目的是综合与当前基于证据的预防和管理NAFLD的生活方式干预措施相关的文献。对文献的综述和综合表明,个性化的营养、运动和行为改变干预措施对管理NAFLD有效。有证据表明,在NAFLD的管理方面存在一些差距。本文讨论的差距包括对该疾病缺乏认识、医患沟通无效、专科医生短缺、对该疾病认识不足以及肝脏健康差异。本文强调了基于证据的克服这些差距的机会,例如利用综合护理模式、临床护理路径和临床实践指南。作为首要接触点的初级保健医生和内分泌学家必须利用这些机会来诊断和管理NAFLD患者。